A carregar...

Results of Phase II Randomized Study of Low-Dose Decitabine with or without Valproic Acid in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia

BACKGROUND: Hypomethylating agents have shown activity in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Pre-clinical and single-arm trials have suggested that adding histone deacetylase (HDAC) inhibitors may synergize the epigenetic modulation of hypomethylating agents and improve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Issa, Jean Pierre, Garcia-Manero, Guillermo, Huang, Xuelin, Cortes, Jorge, Ravandi, Farhad, Jabbour, Elias, Borthakur, Gautam, Brandt, Mark, Pierce, Sherry, Kantarjian, Hagop
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320000/
https://ncbi.nlm.nih.gov/pubmed/25336333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29085
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!